These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Amplification of neurotoxic HTTex1 assemblies in human neurons. Chongtham A; Isas JM; Pandey NK; Rawat A; Yoo JH; Mastro T; Kennedy MB; Langen R; Khoshnan A Neurobiol Dis; 2021 Nov; 159():105517. PubMed ID: 34563643 [TBL] [Abstract][Full Text] [Related]
4. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904 [TBL] [Abstract][Full Text] [Related]
5. An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation. Vieweg S; Ansaloni A; Wang ZM; Warner JB; Lashuel HA J Biol Chem; 2016 Jun; 291(23):12074-86. PubMed ID: 27002149 [TBL] [Abstract][Full Text] [Related]
7. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease. Chen M; Wolynes PG Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517 [TBL] [Abstract][Full Text] [Related]
8. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein. Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716 [TBL] [Abstract][Full Text] [Related]
9. Polyglutamine tracts regulate beclin 1-dependent autophagy. Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460 [TBL] [Abstract][Full Text] [Related]
10. Immiscible inclusion bodies formed by polyglutamine and poly(glycine-alanine) are enriched with distinct proteomes but converge in proteins that are risk factors for disease and involved in protein degradation. Radwan M; Lilley JD; Ang CS; Reid GE; Hatters DM PLoS One; 2020; 15(8):e0233247. PubMed ID: 32857759 [TBL] [Abstract][Full Text] [Related]
11. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset. Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262 [TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia. Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421 [TBL] [Abstract][Full Text] [Related]
14. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation. Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752 [TBL] [Abstract][Full Text] [Related]
15. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease. Arndt JR; Chaibva M; Legleiter J Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791 [TBL] [Abstract][Full Text] [Related]
16. Formation and Structure of Wild Type Huntingtin Exon-1 Fibrils. Isas JM; Langen A; Isas MC; Pandey NK; Siemer AB Biochemistry; 2017 Jul; 56(28):3579-3586. PubMed ID: 28621522 [TBL] [Abstract][Full Text] [Related]
17. Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. Alexandrov AI; Serpionov GV; Kushnirov VV; Ter-Avanesyan MD Prion; 2016 May; 10(3):221-7. PubMed ID: 27220690 [TBL] [Abstract][Full Text] [Related]
18. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease. Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698 [TBL] [Abstract][Full Text] [Related]
19. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Lecerf JM; Shirley TL; Zhu Q; Kazantsev A; Amersdorfer P; Housman DE; Messer A; Huston JS Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4764-9. PubMed ID: 11296304 [TBL] [Abstract][Full Text] [Related]